Skip to content
GenoLensGenoLens

METTL5

Chr 2q31.1

methyltransferase 5, N6-adenosine

Aliases:
HSPC133
MANE:
ENST00000260953.10

Annotations refreshed 9 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • DDG2P

    BIALLELIC, autosomal or pseudoautosomal
  • Intellectual disability

    BIALLELIC, autosomal or pseudoautosomal
  • Severe microcephaly

    BIALLELIC, autosomal or pseudoautosomal

Disease associations (Open Targets)

  • intellectual developmental disorder, autosomal recessive 72

    0.70
  • Severe intellectual disability

    0.43
  • microcephaly with intellectual disability

    0.37
  • autosomal recessive primary microcephaly

    0.37
  • neurodegenerative disease

    0.32
  • hereditary disease

    0.19
  • hepatocellular carcinoma

    0.11
  • gastric cancer

    0.10
  • preeclampsia

    0.09
  • diabetes mellitus

    0.09

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

rRNA N(6)-adenosine-methyltransferase METTL5

Catalytic subunit of a heterodimer with TRMT112, which specifically methylates the 6th position of adenine in position 1832 of 18S rRNA (PubMed:31328227, PubMed:32217665, PubMed:33357433, PubMed:33428944, PubMed:35033535). N6-methylation of adenine(1832) in 18S rRNA resides in the decoding center of 18S rRNA and is required for translation and embryonic stem cells (ESCs) pluripotency and differentiation (PubMed:33357433)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.